In contrast, NAC administration at low concentrations (25–50 μg/kg) not only significantly reduced VEGF-A levels and vascular permeability but also decreased ovarian and uterine weights and favorably altered ovarian morphology by increasing AF counts and decreasing CL numbers. This evidence concerns the gene VEGFA and atrial fibrillation.